Screening for elevated blood lead levels

Ruth A. Etzel, Sophie J. Balk, Cynthia F. Bearer, Mark D. Miller, Michael W. Shannon, Katherine M. Shea, Henry Falk, Lynn R. Goldman, Robert W. Miller, Walter Rogan, Barbara Coven, Birt Harvey, Peter Simon

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Although recent data continue to demonstrate a decline in the prevalence of elevated blood lead levels (BLLs) in children, lead remains a common, preventable, environmental health threat. Because recent epidemiologic data have shown that lead exposure is still common in certain communities in the United States, the Centers for Disease Control and Prevention recently issued new guidelines endorsing universal screening in areas with ≤27% of housing built before 1950 and in populations in which the percentage of 1- and 2- year-olds with elevated BLLs is ≤12%. For children living in other areas, the Centers for Disease Control and Prevention recommends targeted screening based on risk-assessment during specified pediatric visits. In this statement, The American Academy of Pediatrics supports these new guidelines and provides an update on screening for elevated BLLs. The American Academy of Pediatrics recommends that pediatricians continue to provide anticipatory guidance to parents in an effort to prevent lead exposure (primary prevention). Additionally, pediatricians should increase their efforts to screen children at risk for lead exposure to find those with elevated BLLs (secondary prevention).

Original languageEnglish (US)
Pages (from-to)1072-1078
Number of pages7
JournalPediatrics
Volume101
Issue number6
DOIs
StatePublished - Jun 1998
Externally publishedYes

Fingerprint

Centers for Disease Control and Prevention (U.S.)
Pediatrics
Guidelines
Environmental Health
Lead
Primary Prevention
Secondary Prevention
Parents
Population
Pediatricians

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Etzel, R. A., Balk, S. J., Bearer, C. F., Miller, M. D., Shannon, M. W., Shea, K. M., ... Simon, P. (1998). Screening for elevated blood lead levels. Pediatrics, 101(6), 1072-1078. https://doi.org/10.1542/peds.101.6.1072

Screening for elevated blood lead levels. / Etzel, Ruth A.; Balk, Sophie J.; Bearer, Cynthia F.; Miller, Mark D.; Shannon, Michael W.; Shea, Katherine M.; Falk, Henry; Goldman, Lynn R.; Miller, Robert W.; Rogan, Walter; Coven, Barbara; Harvey, Birt; Simon, Peter.

In: Pediatrics, Vol. 101, No. 6, 06.1998, p. 1072-1078.

Research output: Contribution to journalArticle

Etzel, RA, Balk, SJ, Bearer, CF, Miller, MD, Shannon, MW, Shea, KM, Falk, H, Goldman, LR, Miller, RW, Rogan, W, Coven, B, Harvey, B & Simon, P 1998, 'Screening for elevated blood lead levels', Pediatrics, vol. 101, no. 6, pp. 1072-1078. https://doi.org/10.1542/peds.101.6.1072
Etzel RA, Balk SJ, Bearer CF, Miller MD, Shannon MW, Shea KM et al. Screening for elevated blood lead levels. Pediatrics. 1998 Jun;101(6):1072-1078. https://doi.org/10.1542/peds.101.6.1072
Etzel, Ruth A. ; Balk, Sophie J. ; Bearer, Cynthia F. ; Miller, Mark D. ; Shannon, Michael W. ; Shea, Katherine M. ; Falk, Henry ; Goldman, Lynn R. ; Miller, Robert W. ; Rogan, Walter ; Coven, Barbara ; Harvey, Birt ; Simon, Peter. / Screening for elevated blood lead levels. In: Pediatrics. 1998 ; Vol. 101, No. 6. pp. 1072-1078.
@article{c9ac5cee04314099bf5f9cf2052adf57,
title = "Screening for elevated blood lead levels",
abstract = "Although recent data continue to demonstrate a decline in the prevalence of elevated blood lead levels (BLLs) in children, lead remains a common, preventable, environmental health threat. Because recent epidemiologic data have shown that lead exposure is still common in certain communities in the United States, the Centers for Disease Control and Prevention recently issued new guidelines endorsing universal screening in areas with ≤27{\%} of housing built before 1950 and in populations in which the percentage of 1- and 2- year-olds with elevated BLLs is ≤12{\%}. For children living in other areas, the Centers for Disease Control and Prevention recommends targeted screening based on risk-assessment during specified pediatric visits. In this statement, The American Academy of Pediatrics supports these new guidelines and provides an update on screening for elevated BLLs. The American Academy of Pediatrics recommends that pediatricians continue to provide anticipatory guidance to parents in an effort to prevent lead exposure (primary prevention). Additionally, pediatricians should increase their efforts to screen children at risk for lead exposure to find those with elevated BLLs (secondary prevention).",
author = "Etzel, {Ruth A.} and Balk, {Sophie J.} and Bearer, {Cynthia F.} and Miller, {Mark D.} and Shannon, {Michael W.} and Shea, {Katherine M.} and Henry Falk and Goldman, {Lynn R.} and Miller, {Robert W.} and Walter Rogan and Barbara Coven and Birt Harvey and Peter Simon",
year = "1998",
month = "6",
doi = "10.1542/peds.101.6.1072",
language = "English (US)",
volume = "101",
pages = "1072--1078",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "6",

}

TY - JOUR

T1 - Screening for elevated blood lead levels

AU - Etzel, Ruth A.

AU - Balk, Sophie J.

AU - Bearer, Cynthia F.

AU - Miller, Mark D.

AU - Shannon, Michael W.

AU - Shea, Katherine M.

AU - Falk, Henry

AU - Goldman, Lynn R.

AU - Miller, Robert W.

AU - Rogan, Walter

AU - Coven, Barbara

AU - Harvey, Birt

AU - Simon, Peter

PY - 1998/6

Y1 - 1998/6

N2 - Although recent data continue to demonstrate a decline in the prevalence of elevated blood lead levels (BLLs) in children, lead remains a common, preventable, environmental health threat. Because recent epidemiologic data have shown that lead exposure is still common in certain communities in the United States, the Centers for Disease Control and Prevention recently issued new guidelines endorsing universal screening in areas with ≤27% of housing built before 1950 and in populations in which the percentage of 1- and 2- year-olds with elevated BLLs is ≤12%. For children living in other areas, the Centers for Disease Control and Prevention recommends targeted screening based on risk-assessment during specified pediatric visits. In this statement, The American Academy of Pediatrics supports these new guidelines and provides an update on screening for elevated BLLs. The American Academy of Pediatrics recommends that pediatricians continue to provide anticipatory guidance to parents in an effort to prevent lead exposure (primary prevention). Additionally, pediatricians should increase their efforts to screen children at risk for lead exposure to find those with elevated BLLs (secondary prevention).

AB - Although recent data continue to demonstrate a decline in the prevalence of elevated blood lead levels (BLLs) in children, lead remains a common, preventable, environmental health threat. Because recent epidemiologic data have shown that lead exposure is still common in certain communities in the United States, the Centers for Disease Control and Prevention recently issued new guidelines endorsing universal screening in areas with ≤27% of housing built before 1950 and in populations in which the percentage of 1- and 2- year-olds with elevated BLLs is ≤12%. For children living in other areas, the Centers for Disease Control and Prevention recommends targeted screening based on risk-assessment during specified pediatric visits. In this statement, The American Academy of Pediatrics supports these new guidelines and provides an update on screening for elevated BLLs. The American Academy of Pediatrics recommends that pediatricians continue to provide anticipatory guidance to parents in an effort to prevent lead exposure (primary prevention). Additionally, pediatricians should increase their efforts to screen children at risk for lead exposure to find those with elevated BLLs (secondary prevention).

UR - http://www.scopus.com/inward/record.url?scp=0031809840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031809840&partnerID=8YFLogxK

U2 - 10.1542/peds.101.6.1072

DO - 10.1542/peds.101.6.1072

M3 - Article

C2 - 9614424

AN - SCOPUS:0031809840

VL - 101

SP - 1072

EP - 1078

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 6

ER -